Intravenous rhTNK-tPA Bridging With Endovascular Treatment Versus Endovascular Treatment Alone For Stroke Patient With Large Vessel Occlusion: A Multicenter, Randomized Controlled Trial
Latest Information Update: 27 May 2024
Price :
$35 *
At a glance
- Drugs Tenecteplase (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms BRIDGE-TNK
- 21 May 2024 Study design is changed from double-blind to open. Planned patient enrollment is increased.
- 21 May 2024 Planned number of patients changed from 498 to 544.
- 15 Oct 2022 Planned number of patients changed from 586 to 498.